# A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)

> **NCT00398606** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 650 (—)

## Conditions studied

- Osteoporosis, Postmenopausal

## Interventions

- **DRUG:** MK0217, alendronate sodium / Duration of Treatment : 2 Years
- **DRUG:** Comparator : calcium carbonate /Duration of Treatment : 2 Years

## Key facts

- **NCT ID:** NCT00398606
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-04
- **Primary completion:** 1998-02
- **Final completion:** —
- **Target enrollment:** 650 (—)
- **Last updated:** 2022-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00398606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00398606, "A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00398606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*